CD133, one of the markers of cancer stem cells in Hep-2 cell line.
about
Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinomaTargeting Head and Neck Cancer Stem Cells: Current Advances and Future ChallengesNew vessel formation in peritumoral area of squamous cell carcinoma of the head and neck.Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties.Expression of the chemokine receptor CXCR4 in human hepatocellular carcinoma and its role in portal vein tumor thrombus.Contribution of TIP30 to chemoresistance in laryngeal carcinoma.The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics.Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells.Curcumin enhances the effectiveness of cisplatin by suppressing CD133(+) cancer stem cells in laryngeal carcinoma treatmentIdentification of a cancer stem cell-like side population in the HeLa human cervical carcinoma cell line.Head and neck cancer stem cells.The biology of head and neck cancer stem cells.Cancer stem cells, microRNAs, and therapeutic strategies including natural products.CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.Cancer stem cells accountability in progression of head and neck squamous cell carcinoma: the most recent trends!Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells.Cancer stem cells in laryngeal cancer: what we know.The role of miR-145 in stem cell characteristics of human laryngeal squamous cell carcinoma Hep-2 cells.Bmi-1 is essential for the oncogenic potential in CD133(+) human laryngeal cancer cells.Biological characteristics of CD133(+) cancer stem cells derived from human laryngeal carcinoma cell line.Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma.Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck.Orosphere assay: a method for propagation of head and neck cancer stem cells.Snail overexpression induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells.Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells.Cancer stem cells in head and neck squamous cell carcinoma.Differential expression profile analysis of DNA damage repair genes in CD133+/CD133- colorectal cancer cells.Cancer stem cells in head and neck cancer.Implication of stem cells in the biology and therapy of head and neck cancerThe role of head and neck squamous cell carcinoma cancer stem cells in tumorigenesis, metastasis, and treatment failure.Biological and clinical significance of p75NTR expression in laryngeal squamous epithelia and laryngocarcinoma.Identification of three prominin homologs and characterization of their messenger RNA expression in Xenopus laevis tissues.Evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma.Possible involvement of brain tumour stem cells in the emergence of a fast-growing malignant meningioma after surgical resection and radiotherapy of high-grade astrocytoma: case report and preliminary laboratory investigation.Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc.Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.The evolving concepts of cancer stem cells in head and neck squamous cell carcinoma.Immune suppression and evasion in patients with head and neck cancer
P2860
Q33582684-69AE214F-C247-4839-A652-AFE8D977BDE8Q33793000-75BA36B5-968E-464A-935C-B82C5E82BBC1Q34086332-47FC43F8-D603-4A63-85E6-0B942E329364Q34168436-5CE092D3-2A1B-4E14-8067-278742A35EA9Q34408178-4AF41971-732C-4F4D-A598-53E4E7D0E2D5Q34541595-60A70F83-F135-4731-8067-03ACF119F7FEQ34785119-0F685D0C-3A66-4C5F-98BE-CB7F2EEBC243Q36026199-AB70A92E-B738-4C3A-ADF3-8349C63C2016Q36994174-3D5D1475-520B-4DB9-A0B5-ADC5ED9810F1Q37289139-44A6BB08-E8C6-4A5F-98D0-CE8C83DD6EE5Q37324837-2D0B9DCC-EDA0-41F0-B64C-09ECC3AB26B9Q37936020-472AE908-7159-4C45-A676-5C971602D79CQ37954461-A2C1F25C-6AC6-4FD3-AEE8-8BFF905D4BC7Q38023238-2462B089-1991-4FA8-8315-8C3C95EDFC1EQ38035206-E38BA87D-EAFD-4A32-B7B1-BD85E4794101Q38201473-A6B8B2BE-08F4-4212-944D-8F981F576246Q38322466-6D2A64EE-2C20-491A-ADAE-8A1EF3E59CC9Q38639008-35698DBD-6724-4959-A329-EA619842B161Q38826011-327BD378-A791-4DDB-B4FE-3BC54988916DQ38863249-8ADD0FDD-861B-4624-9BB9-F15832A07232Q38943910-DD8D8F90-93E9-4828-97AD-0FA4D708F544Q38954672-CE5F7A44-11E1-4C14-BAF9-4FCD80BA3C35Q39102547-1FFEA6B6-4240-4A57-A53F-B2CA976423A9Q39315396-BD8A8EC3-BFB4-4FAD-90CF-E6B0776FF2FBQ39393642-79101707-E6C0-4151-8A87-0D14CA17471CQ39562499-A93788E3-92B1-4FEA-9E11-25C7772D6B7BQ39817310-D45561D3-F66F-4F5C-8437-2310658FF4C6Q41144456-C077C27D-61D3-4EB5-A049-FBF8AC2B0707Q41944225-EF70E0A6-69B8-4B9F-A282-F1C7214C1783Q42143399-91D34946-35DA-49CC-A521-A18BB9411CFFQ42260347-CAB5B41A-0129-4110-97C8-99392469485FQ42499577-6EA7A0A5-01E1-4CA1-9F3E-1599B7B95DA5Q42747326-C4C7E237-38E0-4C4D-A51E-51F9191AD124Q48572985-B3B6D085-ECB0-4EC8-B68F-1F0D0B5B4A12Q48746123-F118AE15-C115-4999-BE68-30FD75689B5DQ50466048-735E7725-A1F3-44DA-B503-1FE27EBFD7EEQ54616742-66919C50-ACF0-4FC3-8FB3-A4431F494397Q55617784-95CF814A-ACF2-457B-B46F-F2F6B4C909F0Q58289735-9C91747A-430B-4B3C-AC19-037534BDA868
P2860
CD133, one of the markers of cancer stem cells in Hep-2 cell line.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
CD133, one of the markers of cancer stem cells in Hep-2 cell line.
@en
type
label
CD133, one of the markers of cancer stem cells in Hep-2 cell line.
@en
prefLabel
CD133, one of the markers of cancer stem cells in Hep-2 cell line.
@en
P2093
P1433
P1476
CD133, one of the markers of cancer stem cells in Hep-2 cell line.
@en
P2093
Jack J Jiang
Liang Zhou
Xudong Wei
P304
P356
10.1097/01.MLG.0000251586.15299.35
P407
P577
2007-03-01T00:00:00Z